Converge Bio integrates Generative AI with biological data.
Converge Bio has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Converge Bio's investors include Bessemer Venture Partners, TLV Partners, Vintage Investment Partners, Saras Capital, AuroraAxis Capital.
Converge Bio is headquartered in Wilmington, United States.
Converge Bio integrates Generative AI with biological data.
Converge Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Converge Bio — Funding & Investors." VCBacked, January 13, 2026, https://www.vcbacked.co/company/converge-bio. Accessed July 19, 2026.
VCBacked. (2026). Converge Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/converge-bio
{{cite web |title=Converge Bio — Funding & Investors |url=https://www.vcbacked.co/company/converge-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated